Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
NCT07606664 Fezolinetant Hot Flashes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07606664 Fezolinetant Hot Flashes Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07606664 clinical trial report covering Fezolinetant, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07608536 Vonoprazan Fumarate Fibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07608536 Vonoprazan Fumarate Fibrosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07608536 clinical trial report covering Vonoprazan Fumarate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07608432 Zeleciment Rostudirsen Duchenne and Becker Muscular Dystrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07608432 Zeleciment Rostudirsen Duchenne and Becker Muscular Dystrophy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07608432 clinical trial report covering Zeleciment Rostudirsen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262087 Etoposide Small cell lung cancer limited stage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262087 Etoposide Small cell lung cancer limited stage Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262087 clinical trial report covering Etoposide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262125 YJ001 Diabetic peripheral neuropathic pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262125 YJ001 Diabetic peripheral neuropathic pain Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262125 clinical trial report covering YJ001, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07611110 FPI-2265 PSMA-Positive Prostatic Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07611110 FPI-2265 PSMA-Positive Prostatic Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07611110 clinical trial report covering FPI-2265, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
ChiCTR2600125673 Albumin-Bound Paclitaxel Ovarian clear cell carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600125673 Albumin-Bound Paclitaxel Ovarian clear cell carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125673 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07615751 Pyrotinib Maleate Advanced HER2-Positive Breast Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07615751 Pyrotinib Maleate Advanced HER2-Positive Breast Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07615751 clinical trial report covering Pyrotinib Maleate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07613450 SYHA-1813 Meningioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07613450 SYHA-1813 Meningioma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613450 clinical trial report covering SYHA-1813, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07614776 Aflibercept-ayyh Wet age-related macular degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07614776 Aflibercept-ayyh Wet age-related macular degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07614776 clinical trial report covering Aflibercept-ayyh, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07612657 Tacrolimus Pulmonary Arterial Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07612657 Tacrolimus Pulmonary Arterial Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07612657 clinical trial report covering Tacrolimus, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07613294 Lepodisiran sodium Atherosclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07613294 Lepodisiran sodium Atherosclerosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613294 clinical trial report covering Lepodisiran sodium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →